ArticleInternational journal of hematology2018

Improved progression-free and event-free survival in myeloma patients undergoing PBSCH receiving a cyclophosphamide + G-CSF regimen than G-CSF alone.

Akira Tanimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.